Ryan Lake - Dec 31, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Financial Officer
Signature
By: Ryan D. Lake
Stock symbol
SCTL
Transactions as of
Dec 31, 2021
Transactions value $
-$50,832
Form type
4
Date filed
1/4/2022, 08:34 PM
Previous filing
Dec 17, 2021
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability -$49.1K -28.7K -7.79% $1.71 340K Dec 31, 2021 Direct F1
transaction SCTL Common Stock Tax liability -$1.7K -979 -0.29% $1.74 339K Jan 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units.